Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone - PubMed (original) (raw)

Comparative Study

Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone

T Uzawa et al. Bone. 1995 Apr.

Abstract

We compared the effects of synthetic human parathyroid hormone (1-34) (hPTH[1-34]) on rat bones when administered by intermittent injection and by continuous infusion for 4 weeks. Continuous infusion of hPTH(1-34) caused a dose-dependent decrease in the dry weight of the femur and a hyperparathyroidism-like condition in the high-dose group (214 ng/kg/h). In this group, although bone morphology was quite abnormal, the metaphyseal trabecular bone volume increased, whereas the epiphyseal trabecular bone volume tended to decrease, enhancing both bone resorption and formation. The diaphyseal cortical bone of the tibia became markedly porous, and this appeared to be the main cause of the decrease in total bone weight. Conversely, the dry weight of the femur increased in a dose-dependent manner in the intermittent-injection groups. Neither porosity of the cortical bone nor abnormal morphology of the trabecular bone was observed. The volume of the metaphyseal trabecular bone increased while retaining its normal morphology. The epiphyseal trabecular bone formation obviously increased without increase in the number of osteoclasts. In other words, it was postulated that the total weight of bone increased because intermittent injection of hPTH(1-34) increased the trabecular bone volume without loss of the cortical bone volume. These results show that either mode of treatment with hPTH(1-34) continuously accelerated bone formation, whereas the continuous infusion was essential for persistently and markedly enhanced acceleration of bone resorption. It appears that the increase in bone volume with intermittent injection of hPTH(1-34) resulted from the prominent manifestation of its bone-formative action rather than from its bone-resorptive action.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Cited by

Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis.
Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL. Lange U, et al. Osteoporos Int. 2005 Dec;16(12):1999-2004. doi: 10.1007/s00198-005-1990-5. Epub 2005 Sep 20. Osteoporos Int. 2005. PMID: 16172800
Continuous infusion of PTH1-34 delayed fracture healing in mice.
Yukata K, Kanchiku T, Egawa H, Nakamura M, Nishida N, Hashimoto T, Ogasa H, Taguchi T, Yasui N. Yukata K, et al. Sci Rep. 2018 Sep 4;8(1):13175. doi: 10.1038/s41598-018-31345-1. Sci Rep. 2018. PMID: 30181648 Free PMC article.
Repetition of continuous PTH treatments followed by periodic withdrawals exerts anabolic effects on rat bone.
Etoh M, Yamaguchi A. Etoh M, et al. J Bone Miner Metab. 2010 Nov;28(6):641-9. doi: 10.1007/s00774-010-0181-4. J Bone Miner Metab. 2010. PMID: 20393760
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.
Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E. Calvi LM, et al. J Clin Invest. 2001 Feb;107(3):277-86. doi: 10.1172/JCI11296. J Clin Invest. 2001. PMID: 11160151 Free PMC article.
Alternating release of different bioactive molecules from a complexation polymer system.
Jeon JH, Puleo DA. Jeon JH, et al. Biomaterials. 2008 Sep;29(26):3591-8. doi: 10.1016/j.biomaterials.2008.05.011. Epub 2008 Jun 2. Biomaterials. 2008. PMID: 18514812 Free PMC article.

Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone - PubMed (original) (raw)